
Why a 25-cent pill is being sold to cancer patients for nearly $1,000
Apple News In Conversation
00:00
Thalidomide: From Tragedy to Treatment
This chapter explores the controversial history of thalidomide, detailing its initial role in causing birth defects and its unexpected resurgence as a cancer treatment through its derivative, Revlimid. It also examines the ethical implications of drug pricing and the stark contrast between the drug's harmful effects and its potential to save lives in cancer therapy.
Transcript
Play full episode